Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation in diabetic ketoacidosis brains.

William H Hoffman1, Cornelia D Cudrici, Ekaterina Zafranskaia

  • 1Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912, USA.

Experimental and Molecular Pathology
|February 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In situ structure of a bacterial flagellar motor at subnanometre resolution reveals adaptations for increased torque.

Nature microbiology·2025
Same author

Behavior of Complement System Effectors in Chronic and Acute Coronary Artery Disease.

Journal of clinical medicine·2025
Same author

Early expression of neuroinflammation in an untreated fatal case of diabetic ketoacidosis.

Archives of endocrinology and metabolism·2024
Same author

Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis.

Frontiers in immunology·2024
Same author

A unified metric of human immune health.

Nature medicine·2024
Same author

Pilot study to evaluate the safety and effectiveness of etidronate treatment for arterial calcification due to deficiency of CD73 (ACDC).

Vascular medicine (London, England)·2024

Diabetic ketoacidosis (DKA) brain edema involves complement activation and loss of CD59, a protective protein. This suggests complement system involvement in DKA

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Diabetic ketoacidosis (DKA) treatment can cause brain edema, a severe complication with unclear mechanisms.
  • Systemic inflammation and complement cascade activation are implicated in DKA, with elevated SC5b-9 levels observed.

Observation:

  • Studied brains from two patients deceased from DKA-related brain edema.
  • Examined for complement components (C5b-9, C1q) and CD59 expression, alongside apoptosis (TUNEL).

Findings:

  • C5b-9 deposits were found on brain cells (neurons, oligodendrocytes) and blood vessels in DKA patients.
  • C5b-9 co-localized with C1q, indicating classical complement pathway activation.
  • Loss of CD59 expression on brain cells was observed in DKA, contrasting with its presence in normal brains.

Related Experiment Videos

  • C5b-9 was rarely associated with apoptotic neurons and oligodendrocytes.

    • Implications:

    • DKA metabolic crisis leads to CD59 downregulation and C5b-9 deposition in the brain.
    • Complement activation and C5b-9 assembly may contribute to the pathophysiology of DKA-induced brain edema.
    • Further research into complement inhibition could offer therapeutic strategies for DKA brain edema.